ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,572.85
      0.10%
      US Tech 100
      19,963.60
      0.59%
      Dow Jones
      39,344.79
      -0.08%
      Brent Oil
      85.505
      0.11%
      Bitcoin
      57,624.47
      1.62%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. InMed Pharmaceuticals Inc (INM)

      7. InMed Pharmaceuticals Inc (INM) News

      INM

      InMed Pharmaceuticals (INM)

      InMed Pharmaceuticals Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:INM
      DateTimeSourceHeadlineSymbolCompany
      12/19/20224:51PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INMInMed Pharmaceuticals Inc
      12/19/20224:51PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INMInMed Pharmaceuticals Inc
      12/19/20224:51PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INMInMed Pharmaceuticals Inc
      12/19/20224:50PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INMInMed Pharmaceuticals Inc
      12/16/20225:31PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:INMInMed Pharmaceuticals Inc
      12/15/20226:17PMGlobeNewswire Inc.InMed Announces Results of 2022 Annual General MeetingNASDAQ:INMInMed Pharmaceuticals Inc
      12/15/202211:44AMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:INMInMed Pharmaceuticals Inc
      12/15/20226:43AMEdgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:INMInMed Pharmaceuticals Inc
      12/13/20224:02PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:INMInMed Pharmaceuticals Inc
      12/13/20223:48PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:INMInMed Pharmaceuticals Inc
      12/13/20226:02AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:INMInMed Pharmaceuticals Inc
      12/12/20226:47PMGlobeNewswire Inc.InMed Announces Appointment of Interim Chief Financial Officer and Change of AuditorNASDAQ:INMInMed Pharmaceuticals Inc
      12/07/20224:37PMEdgar (US Regulatory)Securities Registration Statement (s-1)NASDAQ:INMInMed Pharmaceuticals Inc
      12/06/20226:02AMEdgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:INMInMed Pharmaceuticals Inc
      11/22/20226:02AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:INMInMed Pharmaceuticals Inc
      11/21/20225:00PMGlobeNewswire Inc.InMed Pharmaceuticals Announces Closing of $6 Million Private Placement Priced at a Premium to MarketNASDAQ:INMInMed Pharmaceuticals Inc
      11/18/20228:00AMGlobeNewswire Inc.InMed Pharmaceuticals Announces $6 Million Private Placement Priced at a Premium to MarketNASDAQ:INMInMed Pharmaceuticals Inc
      11/17/20224:11PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:INMInMed Pharmaceuticals Inc
      11/17/202210:26AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:INMInMed Pharmaceuticals Inc
      11/17/20227:30AMGlobeNewswire Inc.InMed Provides Update on Management ChangesNASDAQ:INMInMed Pharmaceuticals Inc
      11/16/20227:00AMGlobeNewswire Inc.InMed Pharmaceuticals Advances Neurodegenerative Disease Program with Natural Sciences and Engineering Research Council of Canada ("NSERC") Alliance Grant FundingNASDAQ:INMInMed Pharmaceuticals Inc
      11/15/20226:02AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:INMInMed Pharmaceuticals Inc
      11/14/20225:44PMEdgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:INMInMed Pharmaceuticals Inc
      11/11/20226:51PMGlobeNewswire Inc.InMed Pharmaceuticals Reports First Quarter Fiscal 2023 Financial Results and Provides Business UpdateNASDAQ:INMInMed Pharmaceuticals Inc
      11/10/20227:30AMGlobeNewswire Inc.Registration Now Open For Tribe Public’s Webinar Event "Exploring the Neuroprotective Qualities of Rare Cannabinoids" Featuring InMed’s Management Team On November 17, 2022NASDAQ:INMInMed Pharmaceuticals Inc
      10/28/20223:12PMEdgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:INMInMed Pharmaceuticals Inc
      10/28/202212:37PMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:INMInMed Pharmaceuticals Inc
      10/26/20224:11PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:INMInMed Pharmaceuticals Inc
      10/26/20227:30AMGlobeNewswire Inc.InMed Pharmaceuticals Supports Epidermolysis Bullosa Awareness WeekNASDAQ:INMInMed Pharmaceuticals Inc
      10/19/20226:10AMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:INMInMed Pharmaceuticals Inc
       Showing the most relevant articles for your search:NASDAQ:INM